NZ530451A - TIM gene sequences and their use in immunological disorders and cancer - Google Patents

Info

Publication number

NZ530451A

NZ530451A NZ530451A NZ53045102A NZ530451A NZ 530451 A NZ530451 A NZ 530451A NZ 530451 A NZ530451 A NZ 530451A NZ 53045102 A NZ53045102 A NZ 53045102A NZ 530451 A NZ530451 A NZ 530451A

Authority

NZ

New Zealand

Prior art keywords

tim

cells

gene

sequence

nucleic acid

Prior art date

2001-06-29

Links

• Espacenet
• Global Dossier
• Discuss

• 101150022210 tim gene Proteins 0.000 title description 50
• 206010028980 Neoplasm Diseases 0.000 title description 11
• 208000026278 immune system disease Diseases 0.000 title description 6
• 201000011510 cancer Diseases 0.000 title description 2
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 185
• JPSHPWJJSVEEAX-OWPBQMJCSA-N (2s)-2-amino-4-fluoranylpentanedioic acid Chemical group OC(=O)[C@@H](N)CC([18F])C(O)=O JPSHPWJJSVEEAX-OWPBQMJCSA-N 0.000 claims abstract description 133
• 108700028369 Alleles Proteins 0.000 claims abstract description 57
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 42
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 39
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 39
• 239000000523 sample Substances 0.000 claims abstract description 31
• 101150036370 tim-1 gene Proteins 0.000 claims abstract description 21
• 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 14
• 238000001514 detection method Methods 0.000 claims abstract description 14
• 101001068136 Homo sapiens Hepatitis A virus cellular receptor 1 Proteins 0.000 claims abstract description 11
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims abstract description 9
• 102000051539 human HAVCR1 Human genes 0.000 claims abstract description 9
• 238000011830 transgenic mouse model Methods 0.000 claims abstract description 5
• 102100034459 Hepatitis A virus cellular receptor 1 Human genes 0.000 claims description 209
• 108010007712 Hepatitis A Virus Cellular Receptor 1 Proteins 0.000 claims description 131
• 210000004027 cell Anatomy 0.000 claims description 128
• 230000014509 gene expression Effects 0.000 claims description 95
• 238000000034 method Methods 0.000 claims description 59
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 59
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 49
• 229920001184 polypeptide Polymers 0.000 claims description 44
• 230000000694 effects Effects 0.000 claims description 34
• 239000003795 chemical substances by application Substances 0.000 claims description 25
• 238000012216 screening Methods 0.000 claims description 16
• 239000002773 nucleotide Substances 0.000 claims description 13
• 238000000338 in vitro Methods 0.000 claims description 12
• 125000003729 nucleotide group Chemical group 0.000 claims description 12
• 101100284387 Mus musculus Havcr1 gene Proteins 0.000 claims description 9
• 239000013543 active substance Substances 0.000 claims description 8
• 210000005260 human cell Anatomy 0.000 claims description 3
• 101710149792 Triosephosphate isomerase, chloroplastic Proteins 0.000 description 89
• 101710195516 Triosephosphate isomerase, glycosomal Proteins 0.000 description 89
• 241000699670 Mus sp. Species 0.000 description 86
• 102000004169 proteins and genes Human genes 0.000 description 79
• 235000018102 proteins Nutrition 0.000 description 77
• 208000006673 asthma Diseases 0.000 description 73
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 description 72
• 210000001744 T-lymphocyte Anatomy 0.000 description 68
• NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 67
• 241000282414 Homo sapiens Species 0.000 description 59
• 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 description 55
• 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 description 54
• 102000054765 polymorphisms of proteins Human genes 0.000 description 53
• 108020004414 DNA Proteins 0.000 description 51
• 210000000349 chromosome Anatomy 0.000 description 50
• 102000004388 Interleukin-4 Human genes 0.000 description 48
• 108090000978 Interleukin-4 Proteins 0.000 description 48
• 241000699666 Mus <mouse, genus> Species 0.000 description 41
• 208000002200 Respiratory Hypersensitivity Diseases 0.000 description 38
• 230000010085 airway hyperresponsiveness Effects 0.000 description 38
• 108020004999 messenger RNA Proteins 0.000 description 38
• 230000027455 binding Effects 0.000 description 36
• 230000004044 response Effects 0.000 description 35
• 101100369802 Caenorhabditis elegans tim-1 gene Proteins 0.000 description 33
• 241001465754 Metazoa Species 0.000 description 30
• 239000000427 antigen Substances 0.000 description 30
• 108091007433 antigens Proteins 0.000 description 30
• 102000036639 antigens Human genes 0.000 description 30
• 239000012634 fragment Substances 0.000 description 27
• 102000054766 genetic haplotypes Human genes 0.000 description 26
• 108090000695 Cytokines Proteins 0.000 description 25
• 108091054435 TIM family Proteins 0.000 description 25
• 239000002299 complementary DNA Substances 0.000 description 25
• 102000004127 Cytokines Human genes 0.000 description 24
• 238000004458 analytical method Methods 0.000 description 24
• 108060003951 Immunoglobulin Proteins 0.000 description 23
• 101710174757 T-cell immunoglobulin and mucin domain-containing protein 4 Proteins 0.000 description 23
• 102100039367 T-cell immunoglobulin and mucin domain-containing protein 4 Human genes 0.000 description 23
• 230000000692 anti-sense effect Effects 0.000 description 23
• 102000018358 immunoglobulin Human genes 0.000 description 23
• 102000043124 TIM family Human genes 0.000 description 22
• 235000001014 amino acid Nutrition 0.000 description 22
• 150000001413 amino acids Chemical class 0.000 description 22
• 230000006870 function Effects 0.000 description 22
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 21
• 101710174876 Probable triosephosphate isomerase 2 Proteins 0.000 description 21
• 101710174758 T-cell immunoglobulin and mucin domain-containing protein 2 Proteins 0.000 description 21
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 21
• 238000012217 deletion Methods 0.000 description 21
• 230000037430 deletion Effects 0.000 description 21
• 239000013598 vector Substances 0.000 description 21
• 206010003645 Atopy Diseases 0.000 description 20
• 210000001519 tissue Anatomy 0.000 description 20
• 238000011765 DBA/2 mouse Methods 0.000 description 19
• 238000003752 polymerase chain reaction Methods 0.000 description 19
• 239000000047 product Substances 0.000 description 18
• 108091026890 Coding region Proteins 0.000 description 17
• 239000013566 allergen Substances 0.000 description 17
• 238000011161 development Methods 0.000 description 17
• 230000018109 developmental process Effects 0.000 description 17
• 102000003816 Interleukin-13 Human genes 0.000 description 16
• 108090000176 Interleukin-13 Proteins 0.000 description 16
• 230000003993 interaction Effects 0.000 description 16
• 210000004241 Th2 cell Anatomy 0.000 description 15
• 238000003556 assay Methods 0.000 description 15
• 238000004519 manufacturing process Methods 0.000 description 15
• 230000009870 specific binding Effects 0.000 description 15
• 101150046249 Havcr2 gene Proteins 0.000 description 14
• 108091028043 Nucleic acid sequence Proteins 0.000 description 14
• 210000000447 Th1 cell Anatomy 0.000 description 14
• 239000003153 chemical reaction reagent Substances 0.000 description 14
• 210000004443 dendritic cell Anatomy 0.000 description 14
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
• 230000017307 interleukin-4 production Effects 0.000 description 14
• 239000003446 ligand Substances 0.000 description 14
• 230000026731 phosphorylation Effects 0.000 description 14
• 238000006366 phosphorylation reaction Methods 0.000 description 14
• 102000005962 receptors Human genes 0.000 description 14
• 108020003175 receptors Proteins 0.000 description 14
• 241000700159 Rattus Species 0.000 description 13
• 230000004069 differentiation Effects 0.000 description 13
• 230000002068 genetic effect Effects 0.000 description 13
• 230000006798 recombination Effects 0.000 description 13
• 238000005215 recombination Methods 0.000 description 13
• 230000001105 regulatory effect Effects 0.000 description 13
• 230000002103 transcriptional effect Effects 0.000 description 13
• 102100033051 40S ribosomal protein S19 Human genes 0.000 description 12
• 238000003491 array Methods 0.000 description 12
• 230000028993 immune response Effects 0.000 description 12
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
• 241000709721 Hepatovirus A Species 0.000 description 11
• 108010058846 Ovalbumin Proteins 0.000 description 11
• 210000000612 antigen-presenting cell Anatomy 0.000 description 11
• 201000010099 disease Diseases 0.000 description 11
• 108020001507 fusion proteins Proteins 0.000 description 11
• 102000037865 fusion proteins Human genes 0.000 description 11
• 210000004408 hybridoma Anatomy 0.000 description 11
• 238000003780 insertion Methods 0.000 description 11
• 230000037431 insertion Effects 0.000 description 11
• 230000003834 intracellular effect Effects 0.000 description 11
• 229940092253 ovalbumin Drugs 0.000 description 11
• 230000000638 stimulation Effects 0.000 description 11
• 238000011725 BALB/c mouse Methods 0.000 description 10
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 10
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 10
• 230000036428 airway hyperreactivity Effects 0.000 description 10
• 230000033228 biological regulation Effects 0.000 description 10
• 150000001875 compounds Chemical class 0.000 description 10
• 210000002443 helper t lymphocyte Anatomy 0.000 description 10
• 210000003917 human chromosome Anatomy 0.000 description 10
• 229940072221 immunoglobulins Drugs 0.000 description 10
• 230000001965 increasing effect Effects 0.000 description 10
• 239000000203 mixture Substances 0.000 description 10
• 230000002829 reductive effect Effects 0.000 description 10
• 230000002441 reversible effect Effects 0.000 description 10
• 230000004083 survival effect Effects 0.000 description 10
• 238000011282 treatment Methods 0.000 description 10
• 102000004190 Enzymes Human genes 0.000 description 9
• 108090000790 Enzymes Proteins 0.000 description 9
• 102000018697 Membrane Proteins Human genes 0.000 description 9
• 108010052285 Membrane Proteins Proteins 0.000 description 9
• 241001529936 Murinae Species 0.000 description 9
• 208000026935 allergic disease Diseases 0.000 description 9
• 238000013459 approach Methods 0.000 description 9
• 208000010668 atopic eczema Diseases 0.000 description 9
• 229940088598 enzyme Drugs 0.000 description 9
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
• 230000003321 amplification Effects 0.000 description 8
• 230000024245 cell differentiation Effects 0.000 description 8
• 230000001086 cytosolic effect Effects 0.000 description 8
• 239000003814 drug Substances 0.000 description 8
• 239000000499 gel Substances 0.000 description 8
• 238000009396 hybridization Methods 0.000 description 8
• 230000000977 initiatory effect Effects 0.000 description 8
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 8
• 230000035772 mutation Effects 0.000 description 8
• 238000003199 nucleic acid amplification method Methods 0.000 description 8
• 239000013612 plasmid Substances 0.000 description 8
• 230000005855 radiation Effects 0.000 description 8
• 238000006467 substitution reaction Methods 0.000 description 8
• 238000013518 transcription Methods 0.000 description 8
• 230000035897 transcription Effects 0.000 description 8
• 230000009261 transgenic effect Effects 0.000 description 8
• 208000012657 Atopic disease Diseases 0.000 description 7
• 108091060211 Expressed sequence tag Proteins 0.000 description 7
• 241000282412 Homo Species 0.000 description 7
• 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 description 7
• 108010002350 Interleukin-2 Proteins 0.000 description 7
• 102000000588 Interleukin-2 Human genes 0.000 description 7
• 108700026244 Open Reading Frames Proteins 0.000 description 7
• 230000000172 allergic effect Effects 0.000 description 7
• 230000002902 bimodal effect Effects 0.000 description 7
• 230000000295 complement effect Effects 0.000 description 7
• 238000003745 diagnosis Methods 0.000 description 7
• 238000009826 distribution Methods 0.000 description 7
• 239000013604 expression vector Substances 0.000 description 7
• 239000007787 solid Substances 0.000 description 7
• 239000000758 substrate Substances 0.000 description 7
• 239000006228 supernatant Substances 0.000 description 7
• 239000013589 supplement Substances 0.000 description 7
• 230000008685 targeting Effects 0.000 description 7
• 108700024394 Exon Proteins 0.000 description 6
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 6
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 6
• 230000005867 T cell response Effects 0.000 description 6
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 230000016396 cytokine production Effects 0.000 description 6
• 238000002474 experimental method Methods 0.000 description 6
• 239000012530 fluid Substances 0.000 description 6
• 238000001727 in vivo Methods 0.000 description 6
• 208000015181 infectious disease Diseases 0.000 description 6
• 230000005764 inhibitory process Effects 0.000 description 6
• 210000003734 kidney Anatomy 0.000 description 6
• 230000001404 mediated effect Effects 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• 230000008506 pathogenesis Effects 0.000 description 6
• 238000012163 sequencing technique Methods 0.000 description 6
• 238000003786 synthesis reaction Methods 0.000 description 6
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 6
• 241000701161 unidentified adenovirus Species 0.000 description 6
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 5
• 208000023275 Autoimmune disease Diseases 0.000 description 5
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 5
• 206010020751 Hypersensitivity Diseases 0.000 description 5
• 206010061218 Inflammation Diseases 0.000 description 5
• 102000003814 Interleukin-10 Human genes 0.000 description 5
• 108090000174 Interleukin-10 Proteins 0.000 description 5
• 108010065805 Interleukin-12 Proteins 0.000 description 5
• 102000013462 Interleukin-12 Human genes 0.000 description 5
• 102000000743 Interleukin-5 Human genes 0.000 description 5
• 108010002616 Interleukin-5 Proteins 0.000 description 5
• 101001068132 Mus musculus Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 description 5
• 230000004989 O-glycosylation Effects 0.000 description 5
• 108091008874 T cell receptors Proteins 0.000 description 5
• 102000006601 Thymidine Kinase Human genes 0.000 description 5
• 108020004440 Thymidine kinase Proteins 0.000 description 5
• 230000004913 activation Effects 0.000 description 5
• 230000007815 allergy Effects 0.000 description 5
• 239000000074 antisense oligonucleotide Substances 0.000 description 5
• 238000012230 antisense oligonucleotides Methods 0.000 description 5
• 210000004369 blood Anatomy 0.000 description 5
• 239000008280 blood Substances 0.000 description 5
• 238000004113 cell culture Methods 0.000 description 5
• 230000001413 cellular effect Effects 0.000 description 5
• 230000002759 chromosomal effect Effects 0.000 description 5
• 238000003776 cleavage reaction Methods 0.000 description 5
• 238000010367 cloning Methods 0.000 description 5
• 239000012636 effector Substances 0.000 description 5
• 239000003623 enhancer Substances 0.000 description 5
• 230000004927 fusion Effects 0.000 description 5
• 230000007614 genetic variation Effects 0.000 description 5
• 238000003205 genotyping method Methods 0.000 description 5
• 230000003053 immunization Effects 0.000 description 5
• 230000002163 immunogen Effects 0.000 description 5
• 230000004054 inflammatory process Effects 0.000 description 5
• 230000010354 integration Effects 0.000 description 5
• 210000001165 lymph node Anatomy 0.000 description 5
• 239000003550 marker Substances 0.000 description 5
• NZWOPGCLSHLLPA-UHFFFAOYSA-N methacholine Chemical compound C[N+](C)(C)CC(C)OC(C)=O NZWOPGCLSHLLPA-UHFFFAOYSA-N 0.000 description 5
• 229960002329 methacholine Drugs 0.000 description 5
• 210000005259 peripheral blood Anatomy 0.000 description 5
• 239000011886 peripheral blood Substances 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• 108010067815 rat Havcr1protein Proteins 0.000 description 5
• 230000004043 responsiveness Effects 0.000 description 5
• 238000003757 reverse transcription PCR Methods 0.000 description 5
• 230000007017 scission Effects 0.000 description 5
• 230000011664 signaling Effects 0.000 description 5
• 241000894007 species Species 0.000 description 5
• 210000004989 spleen cell Anatomy 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 230000001225 therapeutic effect Effects 0.000 description 5
• 238000002560 therapeutic procedure Methods 0.000 description 5
• 230000014616 translation Effects 0.000 description 5
• 230000003612 virological effect Effects 0.000 description 5
• 238000002965 ELISA Methods 0.000 description 4
• 230000004988 N-glycosylation Effects 0.000 description 4
• 108091000080 Phosphotransferase Proteins 0.000 description 4
• 108700008625 Reporter Genes Proteins 0.000 description 4
• 238000000692 Student's t-test Methods 0.000 description 4
• 230000006044 T cell activation Effects 0.000 description 4
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
• -1 Tim-2 Proteins 0.000 description 4
• 229960004784 allergens Drugs 0.000 description 4
• 229960002685 biotin Drugs 0.000 description 4
• 235000020958 biotin Nutrition 0.000 description 4
• 239000011616 biotin Substances 0.000 description 4
• 210000001185 bone marrow Anatomy 0.000 description 4
• 230000008859 change Effects 0.000 description 4
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 4
• 238000007877 drug screening Methods 0.000 description 4
• 230000007613 environmental effect Effects 0.000 description 4
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 4
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 4
• 238000001502 gel electrophoresis Methods 0.000 description 4
• 238000002744 homologous recombination Methods 0.000 description 4
• 230000006801 homologous recombination Effects 0.000 description 4
• 230000036737 immune function Effects 0.000 description 4
• 210000000987 immune system Anatomy 0.000 description 4
• 238000002649 immunization Methods 0.000 description 4
• 238000003018 immunoassay Methods 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 102000006495 integrins Human genes 0.000 description 4
• 108010044426 integrins Proteins 0.000 description 4
• 238000002372 labelling Methods 0.000 description 4
• 239000006166 lysate Substances 0.000 description 4
• 210000004962 mammalian cell Anatomy 0.000 description 4
• 230000003278 mimic effect Effects 0.000 description 4
• 208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 4
• 210000001616 monocyte Anatomy 0.000 description 4
• 230000007935 neutral effect Effects 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 102000020233 phosphotransferase Human genes 0.000 description 4
• 210000002966 serum Anatomy 0.000 description 4
• 210000000952 spleen Anatomy 0.000 description 4
• 235000000346 sugar Nutrition 0.000 description 4
• 229940124597 therapeutic agent Drugs 0.000 description 4
• 238000013519 translation Methods 0.000 description 4
• 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 4
• 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 3
• 206010003445 Ascites Diseases 0.000 description 3
• 108090001008 Avidin Proteins 0.000 description 3
• 241000894006 Bacteria Species 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 241000282693 Cercopithecidae Species 0.000 description 3
• 108020004635 Complementary DNA Proteins 0.000 description 3
• 102000001301 EGF receptor Human genes 0.000 description 3
• 108060006698 EGF receptor Proteins 0.000 description 3
• 102100031780 Endonuclease Human genes 0.000 description 3
• 102100037815 Fas apoptotic inhibitory molecule 3 Human genes 0.000 description 3
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 3
• 206010071602 Genetic polymorphism Diseases 0.000 description 3
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 3
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 3
• 101710185991 Hepatitis A virus cellular receptor 1 homolog Proteins 0.000 description 3
• 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 3
• 101000878510 Homo sapiens Fas apoptotic inhibitory molecule 3 Proteins 0.000 description 3
• 108090001061 Insulin Proteins 0.000 description 3
• 108091092195 Intron Proteins 0.000 description 3
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 101000669558 Mus musculus T-cell immunoglobulin and mucin domain-containing protein 2 Proteins 0.000 description 3
• 238000012408 PCR amplification Methods 0.000 description 3
• 102000015439 Phospholipases Human genes 0.000 description 3
• 108010064785 Phospholipases Proteins 0.000 description 3
• 206010035226 Plasma cell myeloma Diseases 0.000 description 3
• 241000283984 Rodentia Species 0.000 description 3
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
• 108091081024 Start codon Proteins 0.000 description 3
• 241000700605 Viruses Species 0.000 description 3
• 230000006907 apoptotic process Effects 0.000 description 3
• 201000008937 atopic dermatitis Diseases 0.000 description 3
• 230000001363 autoimmune Effects 0.000 description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000030833 cell death Effects 0.000 description 3
• 238000006243 chemical reaction Methods 0.000 description 3
• 230000009260 cross reactivity Effects 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 238000012239 gene modification Methods 0.000 description 3
• 230000013595 glycosylation Effects 0.000 description 3
• 238000006206 glycosylation reaction Methods 0.000 description 3
• 125000000623 heterocyclic group Chemical group 0.000 description 3
• 210000003630 histaminocyte Anatomy 0.000 description 3
• 238000011534 incubation Methods 0.000 description 3
• 239000003112 inhibitor Substances 0.000 description 3
• 238000011813 knockout mouse model Methods 0.000 description 3
• 210000000265 leukocyte Anatomy 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• 210000002540 macrophage Anatomy 0.000 description 3
• 230000036210 malignancy Effects 0.000 description 3
• 238000013507 mapping Methods 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 201000000050 myeloid neoplasm Diseases 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 3
• 230000000770 proinflammatory effect Effects 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 230000009257 reactivity Effects 0.000 description 3
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 230000001177 retroviral effect Effects 0.000 description 3
• 238000007423 screening assay Methods 0.000 description 3
• 210000004988 splenocyte Anatomy 0.000 description 3
• 238000010186 staining Methods 0.000 description 3
• 238000012360 testing method Methods 0.000 description 3
• 241001430294 unidentified retrovirus Species 0.000 description 3
• BKZOUCVNTCLNFF-IGXZVFLKSA-N (2s)-2-[(2r,3r,4s,5r,6s)-2-hydroxy-6-[(1s)-1-[(2s,5r,7s,8r,9s)-2-[(2r,5s)-5-[(2r,3s,4r,5r)-5-[(2s,3s,4s,5r,6s)-6-hydroxy-4-methoxy-3,5,6-trimethyloxan-2-yl]-4-methoxy-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-7-methoxy-2,8-dimethyl-1,10-dioxaspiro[4.5]dec Chemical compound O([C@@H]1[C@@H]2O[C@H]([C@@H](C)[C@H]2OC)[C@@]2(C)O[C@H](CC2)[C@@]2(C)O[C@]3(O[C@@H]([C@H](C)[C@@H](OC)C3)[C@@H](C)[C@@H]3[C@@H]([C@H](OC)[C@@H](C)[C@](O)([C@H](C)C(O)=O)O3)C)CC2)[C@](C)(O)[C@H](C)[C@@H](OC)[C@@H]1C BKZOUCVNTCLNFF-IGXZVFLKSA-N 0.000 description 2
• 101150029062 15 gene Proteins 0.000 description 2
• ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 2
• NJYVEMPWNAYQQN-UHFFFAOYSA-N 5-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(C(=O)O)=CC=C21 NJYVEMPWNAYQQN-UHFFFAOYSA-N 0.000 description 2
• BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 2
• HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
• 229920000936 Agarose Polymers 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• 102100036444 Clathrin interactor 1 Human genes 0.000 description 2
• 208000016192 Demyelinating disease Diseases 0.000 description 2
• 206010012305 Demyelination Diseases 0.000 description 2
• 206010012438 Dermatitis atopic Diseases 0.000 description 2
• 241000255925 Diptera Species 0.000 description 2
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 2
• 101000851951 Homo sapiens Clathrin interactor 1 Proteins 0.000 description 2
• 101000831286 Homo sapiens Protein timeless homolog Proteins 0.000 description 2
• 241000725303 Human immunodeficiency virus Species 0.000 description 2
• 206010021143 Hypoxia Diseases 0.000 description 2
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• 108010011429 Interleukin-12 Subunit p40 Proteins 0.000 description 2
• 108010002335 Interleukin-9 Proteins 0.000 description 2
• 102000000585 Interleukin-9 Human genes 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• 241000713666 Lentivirus Species 0.000 description 2
• 108091027974 Mature messenger RNA Proteins 0.000 description 2
• 241000712079 Measles morbillivirus Species 0.000 description 2
• 201000003793 Myelodysplastic syndrome Diseases 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 2
• 238000000636 Northern blotting Methods 0.000 description 2
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
• 108700020796 Oncogene Proteins 0.000 description 2
• 102000004264 Osteopontin Human genes 0.000 description 2
• 108010081689 Osteopontin Proteins 0.000 description 2
• 102100026918 Phospholipase A2 Human genes 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 108091008109 Pseudogenes Proteins 0.000 description 2
• 102000057361 Pseudogenes Human genes 0.000 description 2
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
• 241000700157 Rattus norvegicus Species 0.000 description 2
• 101100284388 Rattus norvegicus Havcr1 gene Proteins 0.000 description 2
• 208000037656 Respiratory Sounds Diseases 0.000 description 2
• 206010039085 Rhinitis allergic Diseases 0.000 description 2
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
• 229940124639 Selective inhibitor Drugs 0.000 description 2
• 238000012300 Sequence Analysis Methods 0.000 description 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
• 241000258242 Siphonaptera Species 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 238000002105 Southern blotting Methods 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• 230000024932 T cell mediated immunity Effects 0.000 description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• 101150074789 Timd2 gene Proteins 0.000 description 2
• 108091023040 Transcription factor Proteins 0.000 description 2
• 206010052779 Transplant rejections Diseases 0.000 description 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
• 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 2
• 108070000030 Viral receptors Proteins 0.000 description 2
• 108010066342 Virus Receptors Proteins 0.000 description 2
• 102000018265 Virus Receptors Human genes 0.000 description 2
• 206010047924 Wheezing Diseases 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 238000001042 affinity chromatography Methods 0.000 description 2
• 201000009961 allergic asthma Diseases 0.000 description 2
• 201000010105 allergic rhinitis Diseases 0.000 description 2
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
• 229940037003 alum Drugs 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 210000000628 antibody-producing cell Anatomy 0.000 description 2
• 230000000890 antigenic effect Effects 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 210000003651 basophil Anatomy 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 230000005540 biological transmission Effects 0.000 description 2
• 238000001574 biopsy Methods 0.000 description 2
• 229940098773 bovine serum albumin Drugs 0.000 description 2
• 150000001720 carbohydrates Chemical group 0.000 description 2
• 230000003915 cell function Effects 0.000 description 2
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
• 238000007385 chemical modification Methods 0.000 description 2
• 208000029771 childhood onset asthma Diseases 0.000 description 2
• 210000001072 colon Anatomy 0.000 description 2
• 239000002131 composite material Substances 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 230000007547 defect Effects 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 238000007878 drug screening assay Methods 0.000 description 2
• 201000002491 encephalomyelitis Diseases 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 210000003979 eosinophil Anatomy 0.000 description 2
• 230000002922 epistatic effect Effects 0.000 description 2
• 210000002919 epithelial cell Anatomy 0.000 description 2
• 238000010195 expression analysis Methods 0.000 description 2
• 150000004665 fatty acids Chemical group 0.000 description 2
• 238000000684 flow cytometry Methods 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 125000000524 functional group Chemical group 0.000 description 2
• 239000005090 green fluorescent protein Substances 0.000 description 2
• 238000003306 harvesting Methods 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 230000007954 hypoxia Effects 0.000 description 2
• 210000002865 immune cell Anatomy 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 238000009169 immunotherapy Methods 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 208000027866 inflammatory disease Diseases 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 2
• PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 238000010172 mouse model Methods 0.000 description 2
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical group FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 2
• 229930014626 natural product Natural products 0.000 description 2
• 210000002569 neuron Anatomy 0.000 description 2
• 229920001220 nitrocellulos Polymers 0.000 description 2
• 239000002751 oligonucleotide probe Substances 0.000 description 2
• 238000011275 oncology therapy Methods 0.000 description 2
• 150000002894 organic compounds Chemical class 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 229910052698 phosphorus Inorganic materials 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 239000002157 polynucleotide Substances 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
• 230000035755 proliferation Effects 0.000 description 2
• 230000000069 prophylactic effect Effects 0.000 description 2
• 238000000159 protein binding assay Methods 0.000 description 2
• 230000005180 public health Effects 0.000 description 2
• 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 238000007790 scraping Methods 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 238000005204 segregation Methods 0.000 description 2
• 230000035945 sensitivity Effects 0.000 description 2
• 230000019491 signal transduction Effects 0.000 description 2
• 230000007781 signaling event Effects 0.000 description 2
• 210000003491 skin Anatomy 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000001509 sodium citrate Substances 0.000 description 2
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
• 150000008163 sugars Chemical class 0.000 description 2
• 208000013931 susceptibility to asthma Diseases 0.000 description 2
• 210000001550 testis Anatomy 0.000 description 2
• 210000001541 thymus gland Anatomy 0.000 description 2
• 210000003437 trachea Anatomy 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 238000010396 two-hybrid screening Methods 0.000 description 2
• 230000005951 type IV hypersensitivity Effects 0.000 description 2
• 208000027930 type IV hypersensitivity disease Diseases 0.000 description 2
• 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 2
• 230000003827 upregulation Effects 0.000 description 2
• 231100000611 venom Toxicity 0.000 description 2
• 230000009447 viral pathogenesis Effects 0.000 description 2
• OOIBFPKQHULHSQ-UHFFFAOYSA-N (3-hydroxy-1-adamantyl) 2-methylprop-2-enoate Chemical compound C1C(C2)CC3CC2(O)CC1(OC(=O)C(=C)C)C3 OOIBFPKQHULHSQ-UHFFFAOYSA-N 0.000 description 1
• HFJMJLXCBVKXNY-IVZWLZJFSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C#CC)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 HFJMJLXCBVKXNY-IVZWLZJFSA-N 0.000 description 1
• MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
• CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
• RLGNNNSZZAWLAY-UHFFFAOYSA-N 2-(2,3-dimethoxy-4-methylsulfanylphenyl)ethanamine Chemical compound COC1=C(CCN)C=CC(SC)=C1OC RLGNNNSZZAWLAY-UHFFFAOYSA-N 0.000 description 1
• BFFPVEVGHKMWLT-UHFFFAOYSA-N 2-amino-3,7-dihydropurin-6-one;3,7-dihydropurin-6-one Chemical compound O=C1NC=NC2=C1NC=N2.O=C1NC(N)=NC2=C1NC=N2 BFFPVEVGHKMWLT-UHFFFAOYSA-N 0.000 description 1
• ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
• ZRFXOICDDKDRNA-IVZWLZJFSA-N 4-amino-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidin-2-one Chemical compound O=C1N=C(N)C(C#CC)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 ZRFXOICDDKDRNA-IVZWLZJFSA-N 0.000 description 1
• CKTSBUTUHBMZGZ-ULQXZJNLSA-N 4-amino-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-tritiopyrimidin-2-one Chemical compound O=C1N=C(N)C([3H])=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-ULQXZJNLSA-N 0.000 description 1
• KISUPFXQEHWGAR-RRKCRQDMSA-N 4-amino-5-bromo-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Chemical compound C1=C(Br)C(N)=NC(=O)N1[C@@H]1O[C@H](CO)[C@@H](O)C1 KISUPFXQEHWGAR-RRKCRQDMSA-N 0.000 description 1
• LUCHPKXVUGJYGU-XLPZGREQSA-N 5-methyl-2'-deoxycytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 LUCHPKXVUGJYGU-XLPZGREQSA-N 0.000 description 1
• WQZIDRAQTRIQDX-UHFFFAOYSA-N 6-carboxy-x-rhodamine Chemical compound OC(=O)C1=CC=C(C([O-])=O)C=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 WQZIDRAQTRIQDX-UHFFFAOYSA-N 0.000 description 1
• 101710129138 ATP synthase subunit 9, mitochondrial Proteins 0.000 description 1
• 101710168506 ATP synthase subunit C, plastid Proteins 0.000 description 1
• 101710114069 ATP synthase subunit c Proteins 0.000 description 1
• 101710197943 ATP synthase subunit c, chloroplastic Proteins 0.000 description 1
• 101710187091 ATP synthase subunit c, sodium ion specific Proteins 0.000 description 1
• 241000238876 Acari Species 0.000 description 1
• 241001524031 Aedes sp. Species 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
• 206010002091 Anaesthesia Diseases 0.000 description 1
• 241001520752 Anopheles sp. Species 0.000 description 1
• 241000256844 Apis mellifera Species 0.000 description 1
• 244000105624 Arachis hypogaea Species 0.000 description 1
• 235000007823 Artemisia sp Nutrition 0.000 description 1
• 244000298939 Artemisia sp Species 0.000 description 1
• 241000238421 Arthropoda Species 0.000 description 1
• 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 238000011731 BALB/cByJ (JAX™ mouse strain) Methods 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 235000018185 Betula X alpestris Nutrition 0.000 description 1
• 235000018212 Betula X uliginosa Nutrition 0.000 description 1
• 101710097877 Brain tumor protein Proteins 0.000 description 1
• 206010066091 Bronchial Hyperreactivity Diseases 0.000 description 1
• 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
• 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
• 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
• 101100454807 Caenorhabditis elegans lgg-1 gene Proteins 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 244000025254 Cannabis sativa Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 102000013392 Carboxylesterase Human genes 0.000 description 1
• 108010051152 Carboxylesterase Proteins 0.000 description 1
• 208000005623 Carcinogenesis Diseases 0.000 description 1
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
• 241000134426 Ceratopogonidae Species 0.000 description 1
• 241000282994 Cervidae Species 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
• 241000867607 Chlorocebus sabaeus Species 0.000 description 1
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
• 206010061764 Chromosomal deletion Diseases 0.000 description 1
• 208000017667 Chronic Disease Diseases 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 1
• 108010051219 Cre recombinase Proteins 0.000 description 1
• 241000474140 Ctenocephalides felis felis Species 0.000 description 1
• 241000256054 Culex <genus> Species 0.000 description 1
• 241000256113 Culicidae Species 0.000 description 1
• 241000134316 Culicoides <genus> Species 0.000 description 1
• 241000732108 Culiseta Species 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 238000011767 DBA/2J (JAX™ mouse strain) Methods 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 238000012287 DNA Binding Assay Methods 0.000 description 1
• 239000003298 DNA probe Substances 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 201000004624 Dermatitis Diseases 0.000 description 1
• 206010012434 Dermatitis allergic Diseases 0.000 description 1
• 241000238710 Dermatophagoides Species 0.000 description 1
• LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 241000256868 Dolichovespula maculata Species 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 108010042407 Endonucleases Proteins 0.000 description 1
• 206010014950 Eosinophilia Diseases 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 108010087819 Fc receptors Proteins 0.000 description 1
• 102000009109 Fc receptors Human genes 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 206010016654 Fibrosis Diseases 0.000 description 1
• 208000004262 Food Hypersensitivity Diseases 0.000 description 1
• 206010016946 Food allergy Diseases 0.000 description 1
• 240000009088 Fragaria x ananassa Species 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
• 241000323263 Girgensohnia diptera Species 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 101150071461 HAVCR1 gene Proteins 0.000 description 1
• 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
• 108010027616 Hemoglobin A2 Proteins 0.000 description 1
• 102000007343 Hepatitis A Virus Cellular Receptor 1 Human genes 0.000 description 1
• 108091027305 Heteroduplex Proteins 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 1
• 101000930800 Homo sapiens HLA class II histocompatibility antigen, DQ beta 1 chain Proteins 0.000 description 1
• 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
• 101000669511 Homo sapiens T-cell immunoglobulin and mucin domain-containing protein 4 Proteins 0.000 description 1
• 101000801742 Homo sapiens Triosephosphate isomerase Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 241001243761 Human hepatitis A virus Species 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 108020005350 Initiator Codon Proteins 0.000 description 1
• 102100023915 Insulin Human genes 0.000 description 1
• 102100037850 Interferon gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 102000014158 Interleukin-12 Subunit p40 Human genes 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 108090001090 Lectins Chemical group 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 241000209082 Lolium Species 0.000 description 1
• BKZOUCVNTCLNFF-UHFFFAOYSA-N Lonomycin Natural products COC1C(C)C(C2(C)OC(CC2)C2(C)OC3(OC(C(C)C(OC)C3)C(C)C3C(C(OC)C(C)C(O)(C(C)C(O)=O)O3)C)CC2)OC1C1OC(C)(O)C(C)C(OC)C1C BKZOUCVNTCLNFF-UHFFFAOYSA-N 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• 208000002720 Malnutrition Diseases 0.000 description 1
• 208000007650 Meningeal Carcinomatosis Diseases 0.000 description 1
• 108091092878 Microsatellite Proteins 0.000 description 1
• 102000014171 Milk Proteins Human genes 0.000 description 1
• 108010011756 Milk Proteins Proteins 0.000 description 1
• 241000713869 Moloney murine leukemia virus Species 0.000 description 1
• 101710139349 Mucosal addressin cell adhesion molecule 1 Proteins 0.000 description 1
• 102100028793 Mucosal addressin cell adhesion molecule 1 Human genes 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 101100328463 Mus musculus Cmya5 gene Proteins 0.000 description 1
• 101000669510 Mus musculus T-cell immunoglobulin and mucin domain-containing protein 4 Proteins 0.000 description 1
• 101100369807 Mus musculus Timeless gene Proteins 0.000 description 1
• 101000799443 Mus musculus Triosephosphate isomerase Proteins 0.000 description 1
• 208000010428 Muscle Weakness Diseases 0.000 description 1
• 206010028372 Muscular weakness Diseases 0.000 description 1
• 208000033495 Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality Diseases 0.000 description 1
• 241000736258 Myrmecia <insect> Species 0.000 description 1
• KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 108020003217 Nuclear RNA Proteins 0.000 description 1
• 102000043141 Nuclear RNA Human genes 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 240000007817 Olea europaea Species 0.000 description 1
• 235000002725 Olea europaea Nutrition 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• 241000238887 Ornithodoros Species 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 240000007594 Oryza sativa Species 0.000 description 1
• 235000007164 Oryza sativa Nutrition 0.000 description 1
• 241001480755 Otobius Species 0.000 description 1
• 101710160107 Outer membrane protein A Proteins 0.000 description 1
• 101150030083 PE38 gene Proteins 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 241000392928 Parachromis friedrichsthalii Species 0.000 description 1
• 241001465379 Parietaria judaica Species 0.000 description 1
• 241000721464 Parietaria officinalis Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 241000009328 Perro Species 0.000 description 1
• 241000722350 Phlebotomus <genus> Species 0.000 description 1
• 101710096328 Phospholipase A2 Proteins 0.000 description 1
• 108010058864 Phospholipases A2 Proteins 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 101000737296 Pisum sativum Chlorophyll a-b binding protein AB96 Proteins 0.000 description 1
• 241000209504 Poaceae Species 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 108010091086 Recombinases Proteins 0.000 description 1
• 102000018120 Recombinases Human genes 0.000 description 1
• 108700005075 Regulator Genes Proteins 0.000 description 1
• 206010061481 Renal injury Diseases 0.000 description 1
• 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
• 206010063837 Reperfusion injury Diseases 0.000 description 1
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
• 108050003452 SH2 domains Proteins 0.000 description 1
• 108050008861 SH3 domains Proteins 0.000 description 1
• 108091081021 Sense strand Proteins 0.000 description 1
• 206010070834 Sensitisation Diseases 0.000 description 1
• 229920002684 Sepharose Polymers 0.000 description 1
• 241000256103 Simuliidae Species 0.000 description 1
• 108010053551 Sp1 Transcription Factor Proteins 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 102000019361 Syndecan Human genes 0.000 description 1
• 108050006774 Syndecan Proteins 0.000 description 1
• 108010092262 T-Cell Antigen Receptors Proteins 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 102100030246 Transcription factor Sp1 Human genes 0.000 description 1
• 102000004357 Transferases Human genes 0.000 description 1
• 108090000992 Transferases Proteins 0.000 description 1
• 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 208000024780 Urticaria Diseases 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 241000256840 Vespula maculifrons Species 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 241000353224 Xenopsylla Species 0.000 description 1
• 230000003187 abdominal effect Effects 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 238000007792 addition Methods 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 230000001464 adherent effect Effects 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 208000037883 airway inflammation Diseases 0.000 description 1
• 230000008369 airway response Effects 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 230000009285 allergic inflammation Effects 0.000 description 1
• 108010004469 allophycocyanin Proteins 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229940103272 aluminum potassium sulfate Drugs 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 230000037005 anaesthesia Effects 0.000 description 1
• 239000010775 animal oil Substances 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000012736 aqueous medium Substances 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 239000012752 auxiliary agent Substances 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
• 239000003659 bee venom Substances 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 102000005936 beta-Galactosidase Human genes 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 210000002459 blastocyst Anatomy 0.000 description 1
• 239000002981 blocking agent Substances 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 210000002798 bone marrow cell Anatomy 0.000 description 1
• 230000036427 bronchial hyperreactivity Effects 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 230000036952 cancer formation Effects 0.000 description 1
• 238000005251 capillar electrophoresis Methods 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 108020001778 catalytic domains Proteins 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 230000011712 cell development Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 125000003636 chemical group Chemical group 0.000 description 1
• 230000000973 chemotherapeutic effect Effects 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 229910052804 chromium Inorganic materials 0.000 description 1
• 239000011651 chromium Substances 0.000 description 1
• 208000003053 chromosome 5q deletion syndrome Diseases 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 238000012240 conditional targeting Methods 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 230000000139 costimulatory effect Effects 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 238000009109 curative therapy Methods 0.000 description 1
• 238000011461 current therapy Methods 0.000 description 1
• 230000002559 cytogenic effect Effects 0.000 description 1
• 108010057085 cytokine receptors Proteins 0.000 description 1
• 102000003675 cytokine receptors Human genes 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 1
• MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
• 230000001066 destructive effect Effects 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 239000000385 dialysis solution Substances 0.000 description 1
• 239000010432 diamond Substances 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
• 229960005156 digoxin Drugs 0.000 description 1
• LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
• XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
• 229960002986 dinoprostone Drugs 0.000 description 1
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
• 230000009266 disease activity Effects 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• 235000021186 dishes Nutrition 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
• 239000003596 drug target Substances 0.000 description 1
• 230000004064 dysfunction Effects 0.000 description 1
• 235000014103 egg white Nutrition 0.000 description 1
• 210000000969 egg white Anatomy 0.000 description 1
• 238000002337 electrophoretic mobility shift assay Methods 0.000 description 1
• 238000004836 empirical method Methods 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 230000012202 endocytosis Effects 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 239000002532 enzyme inhibitor Substances 0.000 description 1
• 230000002327 eosinophilic effect Effects 0.000 description 1
• 230000032050 esterification Effects 0.000 description 1
• 238000005886 esterification reaction Methods 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 238000002270 exclusion chromatography Methods 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 208000012997 experimental autoimmune encephalomyelitis Diseases 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 210000003608 fece Anatomy 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 230000004761 fibrosis Effects 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 235000020932 food allergy Nutrition 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 238000012252 genetic analysis Methods 0.000 description 1
• 238000003167 genetic complementation Methods 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 230000008303 genetic mechanism Effects 0.000 description 1
• 230000005017 genetic modification Effects 0.000 description 1
• 235000013617 genetically modified food Nutrition 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 208000005017 glioblastoma Diseases 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 229940046528 grass pollen Drugs 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 208000005252 hepatitis A Diseases 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 238000013537 high throughput screening Methods 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 102000036124 hormone binding proteins Human genes 0.000 description 1
• 108091011044 hormone binding proteins Proteins 0.000 description 1
• 102000049109 human HAVCR2 Human genes 0.000 description 1
• 102000045158 human TIMD4 Human genes 0.000 description 1
• 102000049819 human TIMELESS Human genes 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 201000001421 hyperglycemia Diseases 0.000 description 1
• 230000035874 hyperreactivity Effects 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 230000003100 immobilizing effect Effects 0.000 description 1
• 230000008102 immune modulation Effects 0.000 description 1
• 230000008629 immune suppression Effects 0.000 description 1
• 230000003308 immunostimulating effect Effects 0.000 description 1
• 230000002637 immunotoxin Effects 0.000 description 1
• 229940051026 immunotoxin Drugs 0.000 description 1
• 239000002596 immunotoxin Substances 0.000 description 1
• 231100000608 immunotoxin Toxicity 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 210000004969 inflammatory cell Anatomy 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000002919 insect venom Substances 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 230000031261 interleukin-10 production Effects 0.000 description 1
• 230000018711 interleukin-13 production Effects 0.000 description 1
• 230000009878 intermolecular interaction Effects 0.000 description 1
• 230000031146 intracellular signal transduction Effects 0.000 description 1
• 230000004068 intracellular signaling Effects 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 238000004255 ion exchange chromatography Methods 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 208000037906 ischaemic injury Diseases 0.000 description 1
• 208000028867 ischemia Diseases 0.000 description 1
• 208000012947 ischemia reperfusion injury Diseases 0.000 description 1
• 210000004153 islets of langerhan Anatomy 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 238000011862 kidney biopsy Methods 0.000 description 1
• 208000037806 kidney injury Diseases 0.000 description 1
• 238000011031 large-scale manufacturing process Methods 0.000 description 1
• 239000002523 lectin Chemical group 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 102000019758 lipid binding proteins Human genes 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 231100000053 low toxicity Toxicity 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 239000006249 magnetic particle Substances 0.000 description 1
• 238000002826 magnetic-activated cell sorting Methods 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 210000000415 mammalian chromosome Anatomy 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 210000003071 memory t lymphocyte Anatomy 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 238000002493 microarray Methods 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 235000021239 milk protein Nutrition 0.000 description 1
• 230000003990 molecular pathway Effects 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 238000002887 multiple sequence alignment Methods 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 210000004457 myocytus nodalis Anatomy 0.000 description 1
• DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 230000001613 neoplastic effect Effects 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 235000018343 nutrient deficiency Nutrition 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• 235000014593 oils and fats Nutrition 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 208000035824 paresthesia Diseases 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 235000020232 peanut Nutrition 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 210000003200 peritoneal cavity Anatomy 0.000 description 1
• 102000013415 peroxidase activity proteins Human genes 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• 230000002974 pharmacogenomic effect Effects 0.000 description 1
• 239000002831 pharmacologic agent Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 150000004713 phosphodiesters Chemical group 0.000 description 1
• DCWXELXMIBXGTH-QMMMGPOBSA-N phosphonotyrosine Chemical group OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-QMMMGPOBSA-N 0.000 description 1
• SXADIBFZNXBEGI-UHFFFAOYSA-N phosphoramidous acid Chemical class NP(O)O SXADIBFZNXBEGI-UHFFFAOYSA-N 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical group OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 108010094020 polyglycine Proteins 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 210000001948 pro-b lymphocyte Anatomy 0.000 description 1
• XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 238000002731 protein assay Methods 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 239000012264 purified product Substances 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 150000003230 pyrimidines Chemical class 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 238000002601 radiography Methods 0.000 description 1
• 239000009342 ragweed pollen Substances 0.000 description 1
• 238000011552 rat model Methods 0.000 description 1
• 238000011536 re-plating Methods 0.000 description 1
• 229940051173 recombinant immunotoxin Drugs 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000011514 reflex Effects 0.000 description 1
• 230000024155 regulation of cell adhesion Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 230000003938 response to stress Effects 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• 235000009566 rice Nutrition 0.000 description 1
• 102200004601 rs58918655 Human genes 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 238000003345 scintillation counting Methods 0.000 description 1
• 238000004062 sedimentation Methods 0.000 description 1
• 230000008313 sensitization Effects 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 231100000004 severe toxicity Toxicity 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 206010041232 sneezing Diseases 0.000 description 1
• 230000003393 splenic effect Effects 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 235000021012 strawberries Nutrition 0.000 description 1
• 230000004960 subcellular localization Effects 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 238000004114 suspension culture Methods 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 201000004595 synovitis Diseases 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 238000012353 t test Methods 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 238000002626 targeted therapy Methods 0.000 description 1
• 210000001138 tear Anatomy 0.000 description 1
• 229960000814 tetanus toxoid Drugs 0.000 description 1
• ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
• 238000011287 therapeutic dose Methods 0.000 description 1
• 238000011285 therapeutic regimen Methods 0.000 description 1
• 238000000176 thermal ionisation mass spectrometry Methods 0.000 description 1
• 230000008719 thickening Effects 0.000 description 1
• 208000037816 tissue injury Diseases 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000011820 transgenic animal model Methods 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 108091007466 transmembrane glycoproteins Proteins 0.000 description 1
• 102000035160 transmembrane proteins Human genes 0.000 description 1
• 108091005703 transmembrane proteins Proteins 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 238000013055 trapped ion mobility spectrometry Methods 0.000 description 1
• 201000008827 tuberculosis Diseases 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 239000000717 tumor promoter Substances 0.000 description 1
• 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
• 201000007906 type 1 diabetes mellitus 2 Diseases 0.000 description 1
• 239000005483 tyrosine kinase inhibitor Substances 0.000 description 1
• 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 238000002255 vaccination Methods 0.000 description 1
• 229960005486 vaccine Drugs 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 239000002435 venom Substances 0.000 description 1
• 210000001048 venom Anatomy 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1